CHU Amiens

Amiens 80054

1 studies enrolling now · 9 studies all time

What they study most

Acute Myeloid Leukemia, Colorectal Cancer Metastatic, Crohn Disease, Crohn's Disease, Glycogen Storage Disease Type II, Moderately to Severely Active Crohn Disease, Multiple Myeloma, Myelodysplastic Syndrome, Pancreatic Cancer, Relapsed/Refractory Acute Myeloid Leukemia

Studies at this site

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome — Completed
• Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma — Stopped early
• Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML — Stopped early
• FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer — Completed
• Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer — Completed
• Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602 — Completed